

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.29215287 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.86922563 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.77630690 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.77630690 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.65934038 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.64854031 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.60150355 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.42718978 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.42718978 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.42718978 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.42718978 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.42718978 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.42718978 |
| 14 | locomotory exploration behavior (GO:0035641) | 5.36106338 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.31724823 |
| 16 | vocalization behavior (GO:0071625) | 5.20927690 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 5.20129233 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 5.16629504 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 5.05557087 |
| 20 | detection of other organism (GO:0098543) | 5.01807014 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96803447 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.88172740 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86103122 |
| 24 | protein localization to synapse (GO:0035418) | 4.83931380 |
| 25 | detection of bacterium (GO:0016045) | 4.82088483 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.81843761 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.78713199 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.77851666 |
| 29 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.69973471 |
| 30 | response to peptidoglycan (GO:0032494) | 4.69238232 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.63885214 |
| 32 | prepulse inhibition (GO:0060134) | 4.59706639 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.56867932 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 4.53953963 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 4.50416019 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.47325565 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.46361217 |
| 38 | sodium ion export (GO:0071436) | 4.43765592 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 4.37540332 |
| 40 | cellular extravasation (GO:0045123) | 4.36729226 |
| 41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.34205477 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.30546037 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 4.29299165 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.29258990 |
| 45 | leukocyte aggregation (GO:0070486) | 4.25911024 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 4.24169372 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.23754758 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.22078472 |
| 49 | detection of external biotic stimulus (GO:0098581) | 4.22003227 |
| 50 | neurotransmitter secretion (GO:0007269) | 4.21640463 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.19112474 |
| 52 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.18132959 |
| 53 | neuron-neuron synaptic transmission (GO:0007270) | 4.16517472 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 4.15784449 |
| 55 | exploration behavior (GO:0035640) | 4.15119290 |
| 56 | synaptic transmission, glutamatergic (GO:0035249) | 4.14599523 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 4.11635245 |
| 58 | neutrophil activation (GO:0042119) | 4.11614355 |
| 59 | respiratory burst (GO:0045730) | 4.08965621 |
| 60 | striatum development (GO:0021756) | 4.08708706 |
| 61 | glutamate secretion (GO:0014047) | 4.08304015 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.06809548 |
| 63 | negative regulation of interleukin-12 production (GO:0032695) | 4.06257600 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 4.04494718 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01493480 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 4.00247356 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.99592691 |
| 68 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.97612267 |
| 69 | neuronal action potential propagation (GO:0019227) | 3.93844849 |
| 70 | long-term memory (GO:0007616) | 3.91961596 |
| 71 | synaptic transmission, dopaminergic (GO:0001963) | 3.90176887 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.90039835 |
| 73 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89538451 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.88525387 |
| 75 | dendritic spine morphogenesis (GO:0060997) | 3.88311878 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.88222842 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.87814870 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86883463 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86308804 |
| 80 | response to interleukin-15 (GO:0070672) | 3.83962604 |
| 81 | layer formation in cerebral cortex (GO:0021819) | 3.79954462 |
| 82 | response to host immune response (GO:0052572) | 3.78878040 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.78878040 |
| 84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.76327378 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.73905876 |
| 86 | behavioral response to cocaine (GO:0048148) | 3.73770251 |
| 87 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73387998 |
| 88 | detection of biotic stimulus (GO:0009595) | 3.72831772 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 3.72790241 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 3.71466822 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.71230944 |
| 92 | positive thymic T cell selection (GO:0045059) | 3.70782219 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.69417700 |
| 94 | granulocyte activation (GO:0036230) | 3.69408353 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 3.68826013 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.68001457 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.67846059 |
| 98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.67023095 |
| 99 | negative thymic T cell selection (GO:0045060) | 3.64782285 |
| 100 | auditory behavior (GO:0031223) | 3.63225769 |
| 101 | regulation of leukocyte degranulation (GO:0043300) | 3.62921370 |
| 102 | microglial cell activation (GO:0001774) | 3.62793439 |
| 103 | membrane depolarization during action potential (GO:0086010) | 3.62136118 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 3.62018575 |
| 105 | cell communication by electrical coupling (GO:0010644) | 3.61495038 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.61457133 |
| 107 | defense response to protozoan (GO:0042832) | 3.61170046 |
| 108 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60723007 |
| 109 | macrophage activation (GO:0042116) | 3.60293914 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.59551567 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.57188497 |
| 112 | behavioral fear response (GO:0001662) | 3.56364083 |
| 113 | behavioral defense response (GO:0002209) | 3.56364083 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 3.55950226 |
| 115 | neuron cell-cell adhesion (GO:0007158) | 3.54282576 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.53659241 |
| 117 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.53262828 |
| 118 | mating behavior (GO:0007617) | 3.52356013 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.51686443 |
| 120 | germinal center formation (GO:0002467) | 3.51524024 |
| 121 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.51295796 |
| 122 | neutrophil mediated immunity (GO:0002446) | 3.50740704 |
| 123 | long-term synaptic potentiation (GO:0060291) | 3.50652254 |
| 124 | transmission of nerve impulse (GO:0019226) | 3.49562235 |
| 125 | regulation of synaptic plasticity (GO:0048167) | 3.49253039 |
| 126 | negative T cell selection (GO:0043383) | 3.48688978 |
| 127 | response to host (GO:0075136) | 3.46834398 |
| 128 | response to host defenses (GO:0052200) | 3.46834398 |
| 129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.46834398 |
| 130 | response to auditory stimulus (GO:0010996) | 3.44678400 |
| 131 | positive regulation of neurotransmitter transport (GO:0051590) | 3.44298559 |
| 132 | response to histamine (GO:0034776) | 3.41886355 |
| 133 | neurotransmitter transport (GO:0006836) | 3.37950097 |
| 134 | dopamine receptor signaling pathway (GO:0007212) | 3.37854638 |
| 135 | activation of protein kinase A activity (GO:0034199) | 3.37714505 |
| 136 | potassium ion homeostasis (GO:0055075) | 3.37524136 |
| 137 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.37407609 |
| 138 | regulation of mast cell activation (GO:0033003) | 3.37168105 |
| 139 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.36571418 |
| 140 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.35484546 |
| 141 | regulation of neurotransmitter secretion (GO:0046928) | 3.33919832 |
| 142 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33589838 |
| 143 | cellular response to interleukin-15 (GO:0071350) | 3.32676253 |
| 144 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.32381080 |
| 145 | positive regulation of mast cell degranulation (GO:0043306) | 3.32381080 |
| 146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.31612809 |
| 147 | response to protozoan (GO:0001562) | 3.31435335 |
| 148 | membrane depolarization (GO:0051899) | 3.28893088 |
| 149 | regulation of neurotransmitter transport (GO:0051588) | 3.26583051 |
| 150 | synaptic vesicle endocytosis (GO:0048488) | 3.26149158 |
| 151 | response to amphetamine (GO:0001975) | 3.25801574 |
| 152 | leukocyte degranulation (GO:0043299) | 3.25504472 |
| 153 | fear response (GO:0042596) | 3.24856878 |
| 154 | response to pheromone (GO:0019236) | 3.24778990 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 3.24335275 |
| 156 | regulation of synapse maturation (GO:0090128) | 3.22065601 |
| 157 | regulation of regulated secretory pathway (GO:1903305) | 3.20203794 |
| 158 | T cell selection (GO:0045058) | 3.19977762 |
| 159 | learning (GO:0007612) | 3.19075978 |
| 160 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.16072310 |
| 161 | positive T cell selection (GO:0043368) | 3.15729024 |
| 162 | negative regulation of phagocytosis (GO:0050765) | 3.15659343 |
| 163 | regulation of vesicle fusion (GO:0031338) | 3.15450901 |
| 164 | negative regulation of interleukin-6 production (GO:0032715) | 3.15437716 |
| 165 | visual learning (GO:0008542) | 3.15381023 |
| 166 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14742998 |
| 167 | innervation (GO:0060384) | 3.14372109 |
| 168 | regulation of neurotransmitter levels (GO:0001505) | 3.13394158 |
| 169 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12640905 |
| 170 | neuromuscular process controlling posture (GO:0050884) | 3.12305973 |
| 171 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.12247709 |
| 172 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.12247709 |
| 173 | long term synaptic depression (GO:0060292) | 3.10359572 |
| 174 | B cell mediated immunity (GO:0019724) | 3.10055701 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.09887817 |
| 176 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.09887817 |
| 177 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.09800791 |
| 178 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09619535 |
| 179 | regulation of female receptivity (GO:0045924) | 3.09527476 |
| 180 | regulation of glutamate secretion (GO:0014048) | 3.08422767 |
| 181 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08008563 |
| 182 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07720156 |
| 183 | regulation of neurotransmitter uptake (GO:0051580) | 3.07077872 |
| 184 | synapse assembly (GO:0007416) | 3.04988861 |
| 185 | thymic T cell selection (GO:0045061) | 2.99506498 |
| 186 | T cell migration (GO:0072678) | 2.98756317 |
| 187 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97873489 |
| 188 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96741298 |
| 189 | cellular response to type I interferon (GO:0071357) | 2.95410761 |
| 190 | type I interferon signaling pathway (GO:0060337) | 2.95410761 |
| 191 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94902771 |
| 192 | response to type I interferon (GO:0034340) | 2.94265457 |
| 193 | tolerance induction (GO:0002507) | 2.92447443 |
| 194 | regulation of antigen processing and presentation (GO:0002577) | 2.92014650 |
| 195 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84821558 |
| 196 | activated T cell proliferation (GO:0050798) | 2.83662082 |
| 197 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82307166 |
| 198 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82090627 |
| 199 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.80662938 |
| 200 | positive regulation of regulated secretory pathway (GO:1903307) | 2.80361931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41035832 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.27760024 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05955448 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72295591 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67487065 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49073023 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.48533790 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.26352900 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.18137474 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17294595 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15392208 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09232120 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06992237 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.98434478 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.98170245 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.89964338 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87424561 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.83687481 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83029904 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82745252 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79835773 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.77459125 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.77459125 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.68025371 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65059489 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64364933 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.64095653 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.61705260 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60786360 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59277212 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.55655649 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55263053 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53671354 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53380125 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 2.51127576 |
| 36 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.50519618 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46313462 |
| 38 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.45632905 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44978529 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41687036 |
| 41 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.40899500 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 2.37011459 |
| 43 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36619123 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 2.34522516 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.33606856 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.33049079 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31456033 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.31080704 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.30876524 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.29670206 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29420098 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.25345382 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21945695 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20720790 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17190238 |
| 56 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13513748 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11353519 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 2.09491489 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.05124967 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04978041 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03069539 |
| 62 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02253469 |
| 63 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98911124 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98572845 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97584635 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.94099517 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86721653 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83713846 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74066522 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73896090 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.71412235 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67942057 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67674804 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64222989 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63778870 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62255375 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61161669 |
| 78 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60222970 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58817237 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58067598 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58009681 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55190935 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53912547 |
| 84 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.52278443 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51575848 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51063788 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49484921 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49226134 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44037783 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43326229 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42192637 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41167712 |
| 93 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38977845 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37672505 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37539510 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36607522 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36353345 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.36045224 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34806901 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34606410 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34592737 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34306031 |
| 103 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33907792 |
| 104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33519288 |
| 105 | AR_19668381_ChIP-Seq_PC3_Human | 1.33138453 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32128824 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30337031 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29867401 |
| 109 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28686564 |
| 110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28201749 |
| 111 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27852355 |
| 112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26754149 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25796502 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24595062 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24464668 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24407576 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24314832 |
| 118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24199115 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23728167 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23031667 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22703352 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22604933 |
| 123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22357750 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22093298 |
| 125 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21946102 |
| 126 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21531441 |
| 127 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21269071 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20747598 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19091713 |
| 130 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.18245820 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17517888 |
| 132 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16272241 |
| 133 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15309839 |
| 134 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14857483 |
| 135 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14670284 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14604772 |
| 137 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14395030 |
| 138 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14338580 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13628033 |
| 140 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13504616 |
| 141 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12916914 |
| 142 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12837481 |
| 143 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12631656 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12218805 |
| 145 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11667977 |
| 146 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09755578 |
| 147 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09433492 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09270239 |
| 149 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08910565 |
| 150 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08005631 |
| 151 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07949094 |
| 152 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05998726 |
| 153 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04725374 |
| 154 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03983495 |
| 155 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03648589 |
| 156 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03009314 |
| 157 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02907104 |
| 158 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02747833 |
| 159 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01870975 |
| 160 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01799843 |
| 161 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99696731 |
| 162 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99539111 |
| 163 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99421421 |
| 164 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98256538 |
| 165 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97542884 |
| 166 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97145961 |
| 167 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97040873 |
| 168 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96776350 |
| 169 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96726059 |
| 170 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96338637 |
| 171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95514556 |
| 172 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95414942 |
| 173 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94553469 |
| 174 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94075371 |
| 175 | P68_20966046_ChIP-Seq_HELA_Human | 0.93920340 |
| 176 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93179346 |
| 177 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92837872 |
| 178 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92455444 |
| 179 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92277744 |
| 180 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91764577 |
| 181 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89560348 |
| 182 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88931216 |
| 183 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88857119 |
| 184 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87129831 |
| 185 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86750378 |
| 186 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86469752 |
| 187 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86466114 |
| 188 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86152333 |
| 189 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85978558 |
| 190 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82633006 |
| 191 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82182650 |
| 192 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81926344 |
| 193 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80850056 |
| 194 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79656488 |
| 195 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78358322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.31307361 |
| 2 | MP0002822_catalepsy | 5.12889407 |
| 3 | MP0003880_abnormal_central_pattern | 4.18601938 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.14682547 |
| 5 | MP0003436_decreased_susceptibility_to | 4.08643055 |
| 6 | MP0003724_increased_susceptibility_to | 4.07946953 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.75545256 |
| 8 | MP0003303_peritoneal_inflammation | 3.61234806 |
| 9 | MP0009745_abnormal_behavioral_response | 3.54863045 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.40601860 |
| 11 | MP0004270_analgesia | 3.30736489 |
| 12 | MP0002419_abnormal_innate_immunity | 3.16459024 |
| 13 | MP0002064_seizures | 3.09340587 |
| 14 | MP0009046_muscle_twitch | 3.07291484 |
| 15 | MP0001800_abnormal_humoral_immune | 3.00543376 |
| 16 | MP0000685_abnormal_immune_system | 2.87142481 |
| 17 | MP0005671_abnormal_response_to | 2.86956477 |
| 18 | MP0001790_abnormal_immune_system | 2.86854184 |
| 19 | MP0005387_immune_system_phenotype | 2.86854184 |
| 20 | MP0005025_abnormal_response_to | 2.86339875 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.78915888 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.71188641 |
| 23 | MP0001486_abnormal_startle_reflex | 2.68725896 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.67445539 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.64951723 |
| 26 | MP0002272_abnormal_nervous_system | 2.64902239 |
| 27 | MP0002723_abnormal_immune_serum | 2.64496261 |
| 28 | MP0001819_abnormal_immune_cell | 2.61939683 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.59109104 |
| 30 | MP0003763_abnormal_thymus_physiology | 2.47804967 |
| 31 | MP0001968_abnormal_touch/_nociception | 2.47720296 |
| 32 | MP0009785_altered_susceptibility_to | 2.47631405 |
| 33 | MP0009278_abnormal_bone_marrow | 2.46503760 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 2.36034057 |
| 35 | MP0008260_abnormal_autophagy | 2.35080829 |
| 36 | MP0002396_abnormal_hematopoietic_system | 2.34075629 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 2.30771548 |
| 38 | MP0003300_gastrointestinal_ulcer | 2.30154062 |
| 39 | MP0005464_abnormal_platelet_physiology | 2.28074381 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 2.19416943 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 2.18760071 |
| 42 | MP0003172_abnormal_lysosome_physiology | 2.17413099 |
| 43 | MP0006082_CNS_inflammation | 2.15336786 |
| 44 | MP0002398_abnormal_bone_marrow | 2.13538618 |
| 45 | MP0002405_respiratory_system_inflammati | 2.09481291 |
| 46 | MP0008569_lethality_at_weaning | 2.09050826 |
| 47 | MP0001501_abnormal_sleep_pattern | 2.06583878 |
| 48 | MP0001984_abnormal_olfaction | 2.06495866 |
| 49 | MP0000716_abnormal_immune_system | 2.03311129 |
| 50 | MP0002909_abnormal_adrenal_gland | 2.01146183 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.87993175 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.85928805 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.85928805 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.85917879 |
| 55 | MP0001529_abnormal_vocalization | 1.82508446 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.82472630 |
| 57 | MP0002132_abnormal_respiratory_system | 1.81279137 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.80114129 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.79835527 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.78719042 |
| 61 | MP0004924_abnormal_behavior | 1.76756667 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.76756667 |
| 63 | MP0002736_abnormal_nociception_after | 1.76383453 |
| 64 | MP0002722_abnormal_immune_system | 1.74020486 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.73831878 |
| 66 | MP0002184_abnormal_innervation | 1.71923295 |
| 67 | MP0005310_abnormal_salivary_gland | 1.71432612 |
| 68 | MP0001970_abnormal_pain_threshold | 1.70982288 |
| 69 | MP0004947_skin_inflammation | 1.70813162 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.69937424 |
| 71 | MP0005451_abnormal_body_composition | 1.67827925 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.66871858 |
| 73 | MP0004811_abnormal_neuron_physiology | 1.64134032 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.63919001 |
| 75 | MP0002090_abnormal_vision | 1.62555256 |
| 76 | MP0002429_abnormal_blood_cell | 1.62275437 |
| 77 | MP0002733_abnormal_thermal_nociception | 1.60298919 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.58800657 |
| 79 | MP0003866_abnormal_defecation | 1.57740350 |
| 80 | MP0003828_pulmonary_edema | 1.56075447 |
| 81 | MP0003879_abnormal_hair_cell | 1.54517573 |
| 82 | MP0000751_myopathy | 1.52600005 |
| 83 | MP0003329_amyloid_beta_deposits | 1.51512827 |
| 84 | MP0002735_abnormal_chemical_nociception | 1.49371197 |
| 85 | MP0004381_abnormal_hair_follicle | 1.47964518 |
| 86 | MP0004885_abnormal_endolymph | 1.47417543 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.45484727 |
| 88 | MP0005646_abnormal_pituitary_gland | 1.44914354 |
| 89 | MP0002882_abnormal_neuron_morphology | 1.44828732 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 1.43180897 |
| 91 | MP0009780_abnormal_chondrocyte_physiolo | 1.40413737 |
| 92 | MP0000955_abnormal_spinal_cord | 1.40001316 |
| 93 | MP0000778_abnormal_nervous_system | 1.38369609 |
| 94 | MP0008469_abnormal_protein_level | 1.37934400 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 1.37926930 |
| 96 | MP0001851_eye_inflammation | 1.36065595 |
| 97 | MP0002066_abnormal_motor_capabilities/c | 1.35991729 |
| 98 | MP0003633_abnormal_nervous_system | 1.33658082 |
| 99 | MP0004233_abnormal_muscle_weight | 1.31238479 |
| 100 | MP0009764_decreased_sensitivity_to | 1.30013324 |
| 101 | MP0004858_abnormal_nervous_system | 1.28737993 |
| 102 | MP0004142_abnormal_muscle_tone | 1.28418027 |
| 103 | MP0001188_hyperpigmentation | 1.22684028 |
| 104 | MP0005058_abnormal_lysosome_morphology | 1.20020226 |
| 105 | MP0004215_abnormal_myocardial_fiber | 1.19652277 |
| 106 | MP0002229_neurodegeneration | 1.18743541 |
| 107 | MP0004883_abnormal_blood_vessel | 1.18060656 |
| 108 | MP0004510_myositis | 1.17322235 |
| 109 | MP0002998_abnormal_bone_remodeling | 1.16600790 |
| 110 | MP0002166_altered_tumor_susceptibility | 1.15406640 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 1.15189999 |
| 112 | MP0005253_abnormal_eye_physiology | 1.14755322 |
| 113 | MP0008961_abnormal_basal_metabolism | 1.14272694 |
| 114 | MP0000013_abnormal_adipose_tissue | 1.12114894 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 1.11394327 |
| 116 | MP0004085_abnormal_heartbeat | 1.11376172 |
| 117 | MP0003137_abnormal_impulse_conducting | 1.09393815 |
| 118 | MP0003631_nervous_system_phenotype | 1.08127965 |
| 119 | MP0008872_abnormal_physiological_respon | 1.06637145 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 1.05569799 |
| 121 | MP0002638_abnormal_pupillary_reflex | 1.04652874 |
| 122 | MP0002152_abnormal_brain_morphology | 1.04505484 |
| 123 | MP0001873_stomach_inflammation | 1.02674183 |
| 124 | MP0003075_altered_response_to | 1.00318661 |
| 125 | MP0000858_altered_metastatic_potential | 0.99804460 |
| 126 | MP0001853_heart_inflammation | 0.97463701 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.96508809 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.95879165 |
| 129 | MP0005499_abnormal_olfactory_system | 0.95504097 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.95504097 |
| 131 | MP0001905_abnormal_dopamine_level | 0.95403655 |
| 132 | MP0008874_decreased_physiological_sensi | 0.95080184 |
| 133 | MP0005409_darkened_coat_color | 0.93035635 |
| 134 | MP0002752_abnormal_somatic_nervous | 0.92160869 |
| 135 | MP0003787_abnormal_imprinting | 0.91865782 |
| 136 | MP0001177_atelectasis | 0.91567443 |
| 137 | MP0006276_abnormal_autonomic_nervous | 0.91384782 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.89107138 |
| 139 | MP0001663_abnormal_digestive_system | 0.88098754 |
| 140 | MP0000631_abnormal_neuroendocrine_gland | 0.86158799 |
| 141 | MP0005166_decreased_susceptibility_to | 0.85124347 |
| 142 | MP0005164_abnormal_response_to | 0.83059322 |
| 143 | MP0003634_abnormal_glial_cell | 0.82831581 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.82544383 |
| 145 | MP0005535_abnormal_body_temperature | 0.80924339 |
| 146 | MP0008004_abnormal_stomach_pH | 0.80836395 |
| 147 | MP0005195_abnormal_posterior_eye | 0.80641666 |
| 148 | MP0004036_abnormal_muscle_relaxation | 0.78690268 |
| 149 | MP0005645_abnormal_hypothalamus_physiol | 0.78448082 |
| 150 | MP0009763_increased_sensitivity_to | 0.77301374 |
| 151 | MP0000490_abnormal_crypts_of | 0.77288823 |
| 152 | MP0000343_altered_response_to | 0.76752201 |
| 153 | MP0002009_preneoplasia | 0.74593969 |
| 154 | MP0009765_abnormal_xenobiotic_induced | 0.74374801 |
| 155 | MP0002006_tumorigenesis | 0.72838324 |
| 156 | MP0002837_dystrophic_cardiac_calcinosis | 0.72585299 |
| 157 | MP0005620_abnormal_muscle_contractility | 0.71959920 |
| 158 | MP0000920_abnormal_myelination | 0.71606709 |
| 159 | MP0003690_abnormal_glial_cell | 0.71400571 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.71345957 |
| 161 | MP0003632_abnormal_nervous_system | 0.71320834 |
| 162 | MP0003646_muscle_fatigue | 0.70912842 |
| 163 | MP0003283_abnormal_digestive_organ | 0.69927507 |
| 164 | MP0003045_fibrosis | 0.69807040 |
| 165 | MP0005390_skeleton_phenotype | 0.66709286 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.66554228 |
| 167 | MP0006292_abnormal_olfactory_placode | 0.64610674 |
| 168 | MP0002138_abnormal_hepatobiliary_system | 0.64576181 |
| 169 | MP0004742_abnormal_vestibular_system | 0.64305158 |
| 170 | MP0002019_abnormal_tumor_incidence | 0.64153040 |
| 171 | MP0002933_joint_inflammation | 0.63702463 |
| 172 | MP0002234_abnormal_pharynx_morphology | 0.62729698 |
| 173 | MP0001963_abnormal_hearing_physiology | 0.62448584 |
| 174 | MP0009840_abnormal_foam_cell | 0.62145260 |
| 175 | MP0004130_abnormal_muscle_cell | 0.60468638 |
| 176 | MP0003448_altered_tumor_morphology | 0.60096153 |
| 177 | MP0000604_amyloidosis | 0.59239579 |
| 178 | MP0004043_abnormal_pH_regulation | 0.58991646 |
| 179 | MP0000747_muscle_weakness | 0.58579062 |
| 180 | MP0000249_abnormal_blood_vessel | 0.57367801 |
| 181 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57202842 |
| 182 | MP0003795_abnormal_bone_structure | 0.56915992 |
| 183 | MP0005076_abnormal_cell_differentiation | 0.56504854 |
| 184 | MP0004484_altered_response_of | 0.54986346 |
| 185 | MP0000569_abnormal_digit_pigmentation | 0.54762582 |
| 186 | MP0010234_abnormal_vibrissa_follicle | 0.53659067 |
| 187 | MP0002332_abnormal_exercise_endurance | 0.53272242 |
| 188 | MP0002089_abnormal_postnatal_growth/wei | 0.52465954 |
| 189 | MP0000749_muscle_degeneration | 0.52046968 |
| 190 | MP0002693_abnormal_pancreas_physiology | 0.50874948 |
| 191 | MP0003091_abnormal_cell_migration | 0.46863021 |
| 192 | MP0005381_digestive/alimentary_phenotyp | 0.46465854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.63260174 |
| 2 | Focal motor seizures (HP:0011153) | 7.15597728 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.56603563 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.05002779 |
| 5 | Recurrent abscess formation (HP:0002722) | 6.00497317 |
| 6 | Myositis (HP:0100614) | 5.43144642 |
| 7 | Focal seizures (HP:0007359) | 5.27657231 |
| 8 | Stomatitis (HP:0010280) | 5.05038772 |
| 9 | Visual hallucinations (HP:0002367) | 5.02922878 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.96386797 |
| 11 | Orchitis (HP:0100796) | 4.88126405 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.74503976 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70920960 |
| 14 | Epileptic encephalopathy (HP:0200134) | 4.64438192 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.57155411 |
| 16 | Febrile seizures (HP:0002373) | 4.52396194 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 4.51517912 |
| 18 | Optic neuritis (HP:0100653) | 4.51517912 |
| 19 | Recurrent fungal infections (HP:0002841) | 4.45578247 |
| 20 | Action tremor (HP:0002345) | 4.43369677 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 4.38896214 |
| 22 | Congenital stationary night blindness (HP:0007642) | 4.29722976 |
| 23 | Meningitis (HP:0001287) | 4.29003649 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.25300953 |
| 25 | Obstructive lung disease (HP:0006536) | 4.23578988 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 4.23578988 |
| 27 | Central scotoma (HP:0000603) | 4.20506862 |
| 28 | Absence seizures (HP:0002121) | 4.12630540 |
| 29 | Recurrent skin infections (HP:0001581) | 4.11963769 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.06299928 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 4.06299928 |
| 32 | Dysdiadochokinesis (HP:0002075) | 3.91922039 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.79993007 |
| 34 | Cellulitis (HP:0100658) | 3.76729917 |
| 35 | Dialeptic seizures (HP:0011146) | 3.72521815 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.70816020 |
| 37 | Encephalitis (HP:0002383) | 3.65644928 |
| 38 | Generalized tonic-clonic seizures (HP:0002069) | 3.64365395 |
| 39 | Atonic seizures (HP:0010819) | 3.62817656 |
| 40 | Increased IgE level (HP:0003212) | 3.61871947 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 3.61767283 |
| 42 | Depression (HP:0000716) | 3.53423794 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 3.52311069 |
| 44 | Urticaria (HP:0001025) | 3.49316033 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.47411266 |
| 46 | Prolonged bleeding time (HP:0003010) | 3.42181152 |
| 47 | Gingivitis (HP:0000230) | 3.39896147 |
| 48 | Anxiety (HP:0000739) | 3.39415087 |
| 49 | Broad-based gait (HP:0002136) | 3.38090757 |
| 50 | Poor eye contact (HP:0000817) | 3.37637959 |
| 51 | Vasculitis (HP:0002633) | 3.37084043 |
| 52 | Dysmetric saccades (HP:0000641) | 3.29580298 |
| 53 | Ankle clonus (HP:0011448) | 3.28094892 |
| 54 | Hypochromic anemia (HP:0001931) | 3.25176772 |
| 55 | Agammaglobulinemia (HP:0004432) | 3.23882369 |
| 56 | Recurrent viral infections (HP:0004429) | 3.23304905 |
| 57 | Dysmetria (HP:0001310) | 3.22781166 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 3.20009999 |
| 59 | Scanning speech (HP:0002168) | 3.17223992 |
| 60 | Annular pancreas (HP:0001734) | 3.16581422 |
| 61 | Inflammation of the large intestine (HP:0002037) | 3.13079613 |
| 62 | Abnormality of macular pigmentation (HP:0008002) | 3.12467567 |
| 63 | Chest pain (HP:0100749) | 3.10314832 |
| 64 | Torticollis (HP:0000473) | 3.10228551 |
| 65 | Impaired social interactions (HP:0000735) | 3.09778983 |
| 66 | Abnormal social behavior (HP:0012433) | 3.09778983 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 3.07047720 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.07041564 |
| 69 | Abnormality of the lower motor neuron (HP:0002366) | 3.06531840 |
| 70 | Postural instability (HP:0002172) | 3.01245666 |
| 71 | Episodic fever (HP:0001954) | 2.98476928 |
| 72 | Scotoma (HP:0000575) | 2.97896284 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.95600105 |
| 74 | Ventricular fibrillation (HP:0001663) | 2.94262050 |
| 75 | Supranuclear gaze palsy (HP:0000605) | 2.93795916 |
| 76 | Truncal ataxia (HP:0002078) | 2.93008808 |
| 77 | Colitis (HP:0002583) | 2.90564495 |
| 78 | Pustule (HP:0200039) | 2.89156011 |
| 79 | Genetic anticipation (HP:0003743) | 2.87947197 |
| 80 | Prolonged QT interval (HP:0001657) | 2.87941947 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.86172155 |
| 82 | Mutism (HP:0002300) | 2.84095346 |
| 83 | Hemoptysis (HP:0002105) | 2.83455760 |
| 84 | Osteomyelitis (HP:0002754) | 2.80855075 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.77356765 |
| 86 | Hemiparesis (HP:0001269) | 2.76829651 |
| 87 | Impaired smooth pursuit (HP:0007772) | 2.75374928 |
| 88 | Epistaxis (HP:0000421) | 2.75264714 |
| 89 | Granulocytopenia (HP:0001913) | 2.74454530 |
| 90 | Focal dystonia (HP:0004373) | 2.73466154 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72473712 |
| 92 | Hemiplegia (HP:0002301) | 2.71628463 |
| 93 | Leukocytosis (HP:0001974) | 2.71335584 |
| 94 | T lymphocytopenia (HP:0005403) | 2.70571490 |
| 95 | Abnormality of T cells (HP:0002843) | 2.66311485 |
| 96 | Abnormal EKG (HP:0003115) | 2.63847549 |
| 97 | Intention tremor (HP:0002080) | 2.55829897 |
| 98 | Gingival bleeding (HP:0000225) | 2.55187907 |
| 99 | Abnormality of T cell number (HP:0011839) | 2.54918619 |
| 100 | Resting tremor (HP:0002322) | 2.54304528 |
| 101 | Craniofacial dystonia (HP:0012179) | 2.53981974 |
| 102 | Arterial thrombosis (HP:0004420) | 2.52884974 |
| 103 | Lymphopenia (HP:0001888) | 2.52249457 |
| 104 | IgM deficiency (HP:0002850) | 2.51751190 |
| 105 | Sepsis (HP:0100806) | 2.51065825 |
| 106 | Stereotypic behavior (HP:0000733) | 2.47835460 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 2.47643662 |
| 108 | Amblyopia (HP:0000646) | 2.47120699 |
| 109 | Viral hepatitis (HP:0006562) | 2.46446889 |
| 110 | Abnormal eating behavior (HP:0100738) | 2.46044244 |
| 111 | Pointed chin (HP:0000307) | 2.44909365 |
| 112 | Petechiae (HP:0000967) | 2.44526920 |
| 113 | Microcytic anemia (HP:0001935) | 2.44020734 |
| 114 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.41902456 |
| 115 | Anorexia (HP:0002039) | 2.41881306 |
| 116 | Pulmonary embolism (HP:0002204) | 2.41247650 |
| 117 | Urinary urgency (HP:0000012) | 2.38962514 |
| 118 | Bradykinesia (HP:0002067) | 2.38127876 |
| 119 | Spastic gait (HP:0002064) | 2.37370496 |
| 120 | Amyloidosis (HP:0011034) | 2.33520831 |
| 121 | Exercise-induced myalgia (HP:0003738) | 2.31442358 |
| 122 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30132359 |
| 123 | Peritonitis (HP:0002586) | 2.29500881 |
| 124 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.24476809 |
| 125 | Excessive salivation (HP:0003781) | 2.22009882 |
| 126 | Drooling (HP:0002307) | 2.22009882 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 2.21678966 |
| 128 | Severe visual impairment (HP:0001141) | 2.20626279 |
| 129 | Epileptiform EEG discharges (HP:0011182) | 2.20145593 |
| 130 | Papilloma (HP:0012740) | 2.19904442 |
| 131 | Verrucae (HP:0200043) | 2.19904442 |
| 132 | Status epilepticus (HP:0002133) | 2.19684072 |
| 133 | Incomplete penetrance (HP:0003829) | 2.18247083 |
| 134 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17794960 |
| 135 | Abnormality of the peritoneum (HP:0002585) | 2.17327205 |
| 136 | Abnormality of the pleura (HP:0002103) | 2.13667567 |
| 137 | Hyperventilation (HP:0002883) | 2.11175823 |
| 138 | Impaired vibratory sensation (HP:0002495) | 2.10888009 |
| 139 | Slow saccadic eye movements (HP:0000514) | 2.10792220 |
| 140 | Gastrointestinal stroma tumor (HP:0100723) | 2.09678031 |
| 141 | Fetal akinesia sequence (HP:0001989) | 2.08889625 |
| 142 | Abnormality of the fingertips (HP:0001211) | 2.08880321 |
| 143 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08752283 |
| 144 | Bundle branch block (HP:0011710) | 2.06510179 |
| 145 | Hepatosplenomegaly (HP:0001433) | 2.06285995 |
| 146 | Recurrent sinusitis (HP:0011108) | 2.04673995 |
| 147 | Skin ulcer (HP:0200042) | 2.03971257 |
| 148 | Autoimmune thrombocytopenia (HP:0001973) | 2.03906336 |
| 149 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.02820580 |
| 150 | Loss of speech (HP:0002371) | 2.02045249 |
| 151 | Lower limb amyotrophy (HP:0007210) | 2.02017711 |
| 152 | Primary atrial arrhythmia (HP:0001692) | 2.01953625 |
| 153 | Atrial fibrillation (HP:0005110) | 2.01860122 |
| 154 | Ankyloglossia (HP:0010296) | 1.99463383 |
| 155 | Papilledema (HP:0001085) | 1.99058444 |
| 156 | Chronic otitis media (HP:0000389) | 1.98698540 |
| 157 | Fatigue (HP:0012378) | 1.97824573 |
| 158 | Hypergammaglobulinemia (HP:0010702) | 1.97062330 |
| 159 | Skin rash (HP:0000988) | 1.94570240 |
| 160 | Increased IgM level (HP:0003496) | 1.94390394 |
| 161 | Abnormality of saccadic eye movements (HP:0000570) | 1.94295403 |
| 162 | Recurrent pneumonia (HP:0006532) | 1.94083775 |
| 163 | Clonus (HP:0002169) | 1.94068176 |
| 164 | Gangrene (HP:0100758) | 1.93416137 |
| 165 | Increased serum ferritin (HP:0003281) | 1.93111170 |
| 166 | Eosinophilia (HP:0001880) | 1.92833505 |
| 167 | Lower limb muscle weakness (HP:0007340) | 1.92167466 |
| 168 | Insomnia (HP:0100785) | 1.91430555 |
| 169 | Premature loss of primary teeth (HP:0006323) | 1.90938918 |
| 170 | Diplopia (HP:0000651) | 1.90847648 |
| 171 | Abnormality of binocular vision (HP:0011514) | 1.90847648 |
| 172 | Acute hepatic failure (HP:0006554) | 1.90062250 |
| 173 | Abnormality of iron homeostasis (HP:0011031) | 1.89973644 |
| 174 | Glomerulopathy (HP:0100820) | 1.89329536 |
| 175 | Syncope (HP:0001279) | 1.88713930 |
| 176 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88641007 |
| 177 | Megalencephaly (HP:0001355) | 1.88141770 |
| 178 | Abnormality of the endocardium (HP:0004306) | 1.88081307 |
| 179 | Decreased central vision (HP:0007663) | 1.87590373 |
| 180 | Supraventricular tachycardia (HP:0004755) | 1.87287606 |
| 181 | Recurrent bronchitis (HP:0002837) | 1.86879943 |
| 182 | Progressive inability to walk (HP:0002505) | 1.86725584 |
| 183 | Hypsarrhythmia (HP:0002521) | 1.86365665 |
| 184 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85476725 |
| 185 | Purpura (HP:0000979) | 1.83782913 |
| 186 | Vertigo (HP:0002321) | 1.83228717 |
| 187 | Restrictive lung disease (HP:0002091) | 1.82536177 |
| 188 | Generalized myoclonic seizures (HP:0002123) | 1.82268316 |
| 189 | Supraventricular arrhythmia (HP:0005115) | 1.80097813 |
| 190 | Absent speech (HP:0001344) | 1.79626627 |
| 191 | Gait ataxia (HP:0002066) | 1.76516636 |
| 192 | Pheochromocytoma (HP:0002666) | 1.75027891 |
| 193 | Neurofibrillary tangles (HP:0002185) | 1.74649713 |
| 194 | Limb dystonia (HP:0002451) | 1.74251504 |
| 195 | Lower limb asymmetry (HP:0100559) | 1.73416842 |
| 196 | Distal upper limb amyotrophy (HP:0007149) | 1.72688204 |
| 197 | Upper limb amyotrophy (HP:0009129) | 1.72688204 |
| 198 | Tetraplegia (HP:0002445) | 1.71179008 |
| 199 | Cerebral inclusion bodies (HP:0100314) | 1.71123194 |
| 200 | Rigidity (HP:0002063) | 1.68285151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.04568819 |
| 2 | NTRK3 | 3.98582695 |
| 3 | MAP4K1 | 3.96066115 |
| 4 | MAP3K9 | 3.55815784 |
| 5 | ERN1 | 3.27571789 |
| 6 | MAP2K3 | 3.13005604 |
| 7 | IRAK4 | 3.01815514 |
| 8 | BLK | 3.00364624 |
| 9 | MINK1 | 2.57924732 |
| 10 | MARK1 | 2.50717136 |
| 11 | GRK6 | 2.50199642 |
| 12 | DAPK2 | 2.46112973 |
| 13 | MAP3K4 | 2.44270196 |
| 14 | PAK6 | 2.35983364 |
| 15 | KSR2 | 2.35805187 |
| 16 | TYK2 | 2.34849945 |
| 17 | CAMKK1 | 2.22521745 |
| 18 | PRKD3 | 2.19877547 |
| 19 | CSK | 2.07426375 |
| 20 | BTK | 2.04168073 |
| 21 | RIPK4 | 1.99905486 |
| 22 | NTRK2 | 1.99112666 |
| 23 | SYK | 1.85623943 |
| 24 | KSR1 | 1.81857910 |
| 25 | ZAP70 | 1.81479254 |
| 26 | MAP2K7 | 1.77654901 |
| 27 | PINK1 | 1.76313043 |
| 28 | MAP3K13 | 1.76234186 |
| 29 | MAP3K11 | 1.69300109 |
| 30 | HCK | 1.68844884 |
| 31 | JAK3 | 1.64427998 |
| 32 | STK38 | 1.61971142 |
| 33 | TAOK3 | 1.60568060 |
| 34 | IKBKE | 1.59807327 |
| 35 | MAP3K14 | 1.58637856 |
| 36 | CAMKK2 | 1.58378767 |
| 37 | KIT | 1.57296104 |
| 38 | PRPF4B | 1.57206825 |
| 39 | CDK5 | 1.57117630 |
| 40 | NTRK1 | 1.53412816 |
| 41 | ARAF | 1.52578355 |
| 42 | TXK | 1.50034683 |
| 43 | TNIK | 1.50021552 |
| 44 | EPHB1 | 1.45047638 |
| 45 | SIK2 | 1.43697376 |
| 46 | FES | 1.42569309 |
| 47 | MAP3K3 | 1.41352266 |
| 48 | DAPK1 | 1.39487727 |
| 49 | MAP2K4 | 1.37588352 |
| 50 | NEK1 | 1.35212892 |
| 51 | FGR | 1.34219666 |
| 52 | CSF1R | 1.33802210 |
| 53 | LYN | 1.33642656 |
| 54 | TBK1 | 1.32935729 |
| 55 | PHKG1 | 1.31703381 |
| 56 | PHKG2 | 1.31703381 |
| 57 | ITK | 1.25911638 |
| 58 | JAK2 | 1.23873909 |
| 59 | LCK | 1.20658179 |
| 60 | TAOK1 | 1.19526153 |
| 61 | PRKCG | 1.16868404 |
| 62 | RIPK1 | 1.16511322 |
| 63 | TRIB3 | 1.12950398 |
| 64 | SGK223 | 1.09556048 |
| 65 | SGK494 | 1.09556048 |
| 66 | TYRO3 | 1.09014199 |
| 67 | JAK1 | 1.07047725 |
| 68 | TEC | 1.06939641 |
| 69 | SMG1 | 1.05731083 |
| 70 | RAF1 | 1.03324530 |
| 71 | MARK2 | 1.03083554 |
| 72 | IRAK2 | 1.02546197 |
| 73 | CAMK1 | 0.99612293 |
| 74 | SIK3 | 0.97753316 |
| 75 | IKBKB | 0.94603897 |
| 76 | PLK2 | 0.94282512 |
| 77 | CDK18 | 0.93748451 |
| 78 | MARK3 | 0.93597322 |
| 79 | IRAK1 | 0.93583345 |
| 80 | CAMK2A | 0.93289671 |
| 81 | GRK5 | 0.93140401 |
| 82 | CDK15 | 0.93102914 |
| 83 | SGK2 | 0.92923310 |
| 84 | MAP3K2 | 0.92246435 |
| 85 | MAPK13 | 0.92204887 |
| 86 | MAPK12 | 0.91311557 |
| 87 | STK11 | 0.88806105 |
| 88 | CDK14 | 0.88204882 |
| 89 | CAMK2B | 0.86559011 |
| 90 | PRKCH | 0.86379779 |
| 91 | SGK3 | 0.85867057 |
| 92 | STK10 | 0.85840105 |
| 93 | UHMK1 | 0.84098025 |
| 94 | SGK1 | 0.84021731 |
| 95 | TESK2 | 0.81811554 |
| 96 | CDK11A | 0.81543751 |
| 97 | DYRK1A | 0.81328959 |
| 98 | PTK6 | 0.77419484 |
| 99 | TGFBR2 | 0.77152638 |
| 100 | LMTK2 | 0.75464905 |
| 101 | MATK | 0.74198648 |
| 102 | BMPR2 | 0.73618960 |
| 103 | TNK2 | 0.71862545 |
| 104 | ALK | 0.71518130 |
| 105 | CDK12 | 0.71340490 |
| 106 | MAP3K7 | 0.69335066 |
| 107 | PDK1 | 0.68089595 |
| 108 | RET | 0.67270767 |
| 109 | PIM1 | 0.67059905 |
| 110 | YES1 | 0.65545366 |
| 111 | LRRK2 | 0.64916112 |
| 112 | CAMK2D | 0.64351967 |
| 113 | RPS6KA3 | 0.63467499 |
| 114 | MAP3K6 | 0.62900035 |
| 115 | CAMK4 | 0.61932972 |
| 116 | PAK3 | 0.61927156 |
| 117 | PTK2B | 0.61740785 |
| 118 | HIPK2 | 0.61461919 |
| 119 | PRKCQ | 0.61438589 |
| 120 | DMPK | 0.61313769 |
| 121 | PDPK1 | 0.60763232 |
| 122 | NEK6 | 0.60309783 |
| 123 | CDK19 | 0.58706629 |
| 124 | PRKCZ | 0.56602335 |
| 125 | MAP3K12 | 0.56462975 |
| 126 | DYRK1B | 0.56436859 |
| 127 | MAPK7 | 0.55142362 |
| 128 | WNK1 | 0.54619699 |
| 129 | CASK | 0.54568536 |
| 130 | CAMK1D | 0.54251743 |
| 131 | NME1 | 0.53381249 |
| 132 | MAP3K1 | 0.51799233 |
| 133 | FYN | 0.51598069 |
| 134 | MAPK10 | 0.51443634 |
| 135 | CAMK2G | 0.50711778 |
| 136 | PIK3CG | 0.50280376 |
| 137 | GRK7 | 0.50204016 |
| 138 | RPS6KL1 | 0.49628152 |
| 139 | RPS6KC1 | 0.49628152 |
| 140 | MAP2K6 | 0.49607054 |
| 141 | CDC42BPA | 0.48500276 |
| 142 | FGFR3 | 0.48180614 |
| 143 | PNCK | 0.47351432 |
| 144 | MAP3K10 | 0.46530803 |
| 145 | CDK4 | 0.45804570 |
| 146 | SCYL2 | 0.45344122 |
| 147 | PRKCE | 0.44155106 |
| 148 | MAP2K1 | 0.42967032 |
| 149 | BRAF | 0.42614821 |
| 150 | CSNK1G2 | 0.42411380 |
| 151 | RPS6KA6 | 0.41919399 |
| 152 | PRKCB | 0.41033136 |
| 153 | LATS2 | 0.40164256 |
| 154 | PRKACA | 0.37671100 |
| 155 | DAPK3 | 0.36976482 |
| 156 | TAOK2 | 0.36327304 |
| 157 | PRKD2 | 0.35468003 |
| 158 | ICK | 0.35445829 |
| 159 | PRKCA | 0.34839500 |
| 160 | MAPK8 | 0.33782909 |
| 161 | FGFR4 | 0.33044354 |
| 162 | PRKACG | 0.32874194 |
| 163 | BRSK1 | 0.32312178 |
| 164 | MAP3K5 | 0.32151854 |
| 165 | SIK1 | 0.30734630 |
| 166 | NLK | 0.30233545 |
| 167 | MAPK11 | 0.28352519 |
| 168 | PRKD1 | 0.28014346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83082443 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.06087431 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.05899160 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.05819432 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02199549 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.92740274 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.89112320 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.89017645 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.81453466 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63993350 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.60275360 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.59778750 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.48311650 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.40587445 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.38827626 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.35210101 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31970800 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21130591 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20131495 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.18013863 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 2.17077992 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14530417 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 2.13642963 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.11639570 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.04875186 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.97102702 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.95726545 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.93701633 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.92187122 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91457766 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.86393453 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84904413 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83342790 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.82952403 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.82882706 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.79606511 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73825191 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72377921 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.68920206 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65481682 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62247704 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.62124155 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61996548 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.61621440 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.60808322 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60270802 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59578614 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.59155739 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58402471 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54476705 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.54250706 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49954813 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.43763373 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41868828 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39454697 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.39040883 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37305594 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35973546 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35620730 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34633313 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33893728 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28336303 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27800809 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 1.24882664 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24862376 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24434288 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22061375 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 1.20257615 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19358923 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18928779 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16392170 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14715637 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13340882 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 1.12010258 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11009316 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.08425127 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07753177 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05329872 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05183532 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02228754 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99194095 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99107382 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98187812 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97478746 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.95273092 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94966348 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93917182 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93816371 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.93448361 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90873025 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.90618052 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89123774 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.87314066 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85293800 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83836518 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.81963716 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80852243 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.80784949 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.80731388 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80293356 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.78743388 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78058780 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77347117 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76812623 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.75631932 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73482577 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73046695 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72259990 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70658506 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69427428 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68462867 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67861276 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66788911 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66740743 |
| 115 | Alcoholism_Homo sapiens_hsa05034 | 0.66605160 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66026947 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65485484 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64931783 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64921845 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63575094 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61634322 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60433693 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59225441 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58691843 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57945938 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57046927 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.56515126 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55688590 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55007063 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54609847 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54378944 |
| 132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54101890 |
| 133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53308837 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52181585 |
| 135 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52083403 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50864304 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50622768 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49318852 |
| 139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47192555 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46983817 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46854704 |
| 142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46168583 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46156366 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.45730939 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44315997 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43126652 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42904757 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.41187194 |
| 149 | Endocytosis_Homo sapiens_hsa04144 | 0.40288067 |
| 150 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40205151 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38420531 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36121426 |
| 153 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35045345 |
| 154 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34582356 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34265378 |
| 156 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32186766 |
| 157 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32065250 |
| 158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31861733 |
| 159 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27923965 |
| 160 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24802711 |
| 161 | Prion diseases_Homo sapiens_hsa05020 | 0.24380326 |
| 162 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23681155 |
| 163 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23207445 |
| 164 | Mineral absorption_Homo sapiens_hsa04978 | 0.21546759 |
| 165 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20708485 |
| 166 | Platelet activation_Homo sapiens_hsa04611 | 0.20675198 |
| 167 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19114545 |

